Abstract
Crohn's disease and ulcerative colitis show afamilial aggregation. The role of antinuclearautoantibodies, which occur in both diseases, remains tobe defined. In 76 patients with Crohn's disease, 61patients with ulcerative colitis, 105 first-degreerelatives of patients with Crohn's disease, 101first-degree relatives of patients with ulcerativecolitis, and 40 healthy unrelated controls antinuclearautoantibodies were detected by indirect immunofluorescence.Existence of autoantibodies was correlated with clinicalfeatures. Eighteen percent of patients with Crohn'sdisease (14/76), 43% of patients with ulcerative colitis (26/61), 13% of relatives of patientswith Crohn's disease (14/105), 24% of relatives ofulcerative colitis patients (24/101), and 2% of thehealthy controls (1/40) were positive for antinuclear autoantibodies. The difference between controlsand patients and the first-degree relatives of patientswith ulcerative colitis, respectively, was statisticallysignificant (P ≤ 0.0144). In ulcerative colitis, the existence of antinuclear autoantibodies wasnegatively correlated with immunosuppressive therapy orextraintestinal manifestations (P = 0.0004 and 0.0273,respectively). Antinuclear autoantibodies may represent a factor disposing to the developmentof ulcerative colitis.
Similar content being viewed by others
REFERENCES
Zauli D, Crespi C, Dall Amore P, Bianchi FB, Pisi E: Antibodies to the cytoskeleton components and other autoantibodies in inflammatory bowel disease. Digestion 32:140–144, 1985
Hibi T, Ohara M, Toda K, Hara A, Ogata H, Iwao Y, Watanabe N, Watanabe M, Hamada Y, Kobayashi K: In vitro anticolon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis. Gut 31:1371–1376, 1990
Saxon A, Shanahan F, Landers C, Ganz T, Targan S: A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 86:202–210, 1990
Seibold F, Weber P, Jenss H, Wiedmann KH: Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: Specific markers for a subgroup of patients with Crohn's disease. Gut 32:1192–1197, 1991
Stocker W, Otte M, Scriba PC: Immunopathogenesis of Crohn's disease. Dtsch Med Wochenschr 109:1984–1986, 1984
Podolsky DK: Inflammatory bowel disease (2). N Engl J Med 325:1008–1016, 1992
Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F: Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 100:1590–1596, 1991
Dalekos GN, Manoussakis MN, Goussia AC, Tsianos EV, Moutsopoulos HM: Soluble interleukin-2 receptors, antineutrophil cytoplasmatic antibodies, and other autoantibodies in patients with ulcerative colitis. Gut 34:658–664, 1993
Reumaux D, Meziere C, Colombel JF, Duthilleul P, Mueller S: Distinct production of autoantibodies to nuclear components in ulcerative colitis and Crohn's disease. Clin Immunol Immunopathol 77:349–357, 1995
Farmer RG: Association of inflammatory bowel disease in families. Front Gastrointest Res 11:235–241, 1986
Fiocchi C, Roche JK, Michener WM: High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives. Ann Intern Med 110:786–794, 1989
Czaja AJ, Manns MP: The validity and importance of subtypes in autoimmune hepatitis: A point of view. Am J Gastroenterol 90:1206–1211, 1995
Mohan C, Datta SK: Lupus: Key pathogenic mechanisms and contributing factors. Clin Immunol Immunopathol 77:209–220, 1995
Godeau P, Piette JC, Frances C, Huong Du LT, Bletry O, Wechsler B: The multiple clinical aspects of lupus. Clin Exp Rheumatol, Suppl 5:27–35, 1990
Brey RL: Antiphospholipid antibodies and stroke. Heart Dis Stroke 1:379–382, 1992
Cameron JS, Frampton G: The antiphospholipid syndrome and the lupus anticoagulant. Pediatr Nephrol 4:663–678, 1990
Lam A, Borda IT, Inwood MJ, Thomson S: Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology 68:245–251, 1975
Vecchi M, Cattaneo M, de Franchis R, Mannucci PM: Risk of thromboembolic complications in patients with inflammatory bowel disease. Study of hemostasis measurements. Int J Clin Lab Res 21:165–170, 1991
Hudson M, Hutton RA, Wakefield AJ, Sawyerr AM, Pounder RE: Evidence for activation of coagulation in Crohn's disease. Blood Coagul Fibrinolysis 3:773–778, 1992
Sankey EA, Dhillon AP, Anthony A, Wakefield AJ, Sim R, More L, Hudson M, Sawyerr AM, Pounder RE: Early mucosal changes in Crohn's disease. Gut 34:375–381, 1993
Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Rowles PM, Lewis AA, Pounder RE: Pathogenesis of Crohn's disease: Multifocal gastrointestinal infarction. Lancet 2(8671):1057–1062, 1989
Thompson NP, Wakefield AJ, Pounder RE: Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 108:1011–1015, 1995
Bennet RA, Rubin PH, Present DH: Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease. Gastroenterology 100:1638–1643, 1991
Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B: Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29:990–996, 1988
Colombel JF, Grandbastien B, Gower-Russeau C, Plegat S, Evrard JP, Dupas JL, Gendre JP, Modigliani R, Belaiche J, Hostein J, Hugot JP, Van Kruiningen H, Cortot A: Clinical characteristics of Crohn's disease in 72 families. Gastroenterology 111:604–607, 1996
Bayless TM, Tokayer AZ, Polito JM, Quaskey SA, Mellits ED, Harris LM: Crohn's disease: Concordance for site and clinical type in affected family members-potential hereditary influences. Gastroenterology 111:573–579, 1996
Polito MJ, Rees CR, Childs B, Mendeloff AI, Harris LM, Bayless TM: Preliminary evidence for genetic anticipation in Crohn's disease. Lancet 347:798–800, 1996
Polito JM, Childs B, Mellits DE, Tokayer AZ, Harris LM, Bayless TM: Crohn's disease: Influence of age at diagnosis on site and clinical type of disease. Gastroenterology 111:580–586, 1996
Peeters M, Nevens H, Baert F, Hiele M, De Meyer AM, Vlietinck R, Ruutgerts P: Familial aggregation in Crohn's disease: Increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 111:597–603, 1996
Satsangi J, Grootscholten C, Holt H, Jewell DP: Clinical patterns of familial inflammatory bowel disease. Gut 38:738–741, 1996
Calkins BM, Mendeloff AI: Epidemiology of inflammatory bowel disease. Epidemiol Rev 8:60–91, 1986
Shanahan F, Duerr HR, Rotter IJ, Yang H, Sutherland RL, McElree C, Landers JC, Targan SR: Neutrophil autoantibodies in ulcerative colitis: Familial aggregation and genetic heterogeneity. Gastroenterology 103:456–461, 1992
Seibold F, Slametschka D, Gregor M, Weber P: Neutrophil autoantibodies: A genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 107:532–536, 1994
Reumaux D, Delecourt L, Colombel JF, Noel LH, Duthilleul P, Cortot A: Anti-neutrophil cytoplasmic autoantibodies in relatives of patients with ulcerative colitis. Gastroenterology 103:1706, 1992 (letter; comment)
Monteleone G, Doldo P, Marasco R, Parello T, Imeneo M, DeMedici A, Giglio A, Luzza F, Pallone F: Perinuclear neutrophil autoantibodies (p-ANCA) in unaffected relatives of patients with ulcerative colitis (UC). Suggestions against familial aggregation. Gut 35(suppl 4):A31, 1994
Lee JC, Lennard-Jones JE, Cambridge G: Antineutrophil antibodies in familial inflammatory bowel disease. Gastroenterology 108:428–433, 1995
Papo M, Quer JC, Pastor MR, Garcia-Pardo G, Prats E, Mirapeix E, Rodriguez R, Richart C: Antineutrophil cytoplasmatic antibodies in relatives of patients with inflammatory bowel disease. Am J Gastroenterol 91:1512–1515, 1996
Folwaczny C, Noehl N, Endres SP, Heldwein W, Loeschke K, Fricke H: Anti-goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives. Gastroenterology (in press)
Rights and permissions
About this article
Cite this article
Folwaczny, C., Noehl, N., Endres, S. et al. Antinuclear Autoantibodies in Patients with Inflammatory Bowel Disease (High Prevalence in First-Degree Relatives). Dig Dis Sci 42, 1593–1597 (1997). https://doi.org/10.1023/A:1018832608899
Issue Date:
DOI: https://doi.org/10.1023/A:1018832608899